Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1987 May;91(1):165–169. doi: 10.1111/j.1476-5381.1987.tb08995.x

Cytoprotective effects of disodium cromoglycate on rat stomach mucosa.

J Goossens, J Van Reempts, J P Van Wauwe
PMCID: PMC1853475  PMID: 3109535

Abstract

The cytoprotective effects of the anti-asthmatic drug, disodium cromoglycate (DSCG), on gastric mucosal necrosis induced by ethanol in rats were studied. Subcutaneous, but not oral, DSCG prevented the formation of gastric lesions and this effect was dose-dependent between 1.25 and 40 mg kg-1, with an ED50 value of 6.8 mg kg-1. Maximal cytoprotection occurred 15-30 min after DSCG treatment. Histological examination revealed that DSCG effectively protected the gastric mucosa against ethanol-induced vascular congestion, haemorrhage, epithelial desquamation and mucosal oedema. Enhanced production of endogenous prostaglandins, which are known cytoprotective compounds, could not explain the mucosal protection. At a dose of 40 mg kg-1, DSCG did not change prostaglandin E2 or 6-keto-prostaglandin F1 alpha concentrations in gastric mucosal tissue, although its cytoprotective activity was partially inhibited by prior treatment of the animals with indomethacin.

Full text

PDF
165

Images in this article

167Figure 2
on p.167

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. André C., Gillon J., Moulinier B., Martin A., Fargier M. C. Randomised placebo-controlled double-blind trial of two dosages of sodium cromoglycate in treatment of varioliform gastritis: comparison with cimetidine. Gut. 1982 Apr;23(4):348–352. doi: 10.1136/gut.23.4.348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barnes P. J. Asthma as an axon reflex. Lancet. 1986 Feb 1;1(8475):242–245. doi: 10.1016/s0140-6736(86)90777-4. [DOI] [PubMed] [Google Scholar]
  3. Basran G. S., Page C. P., Paul W., Morley J. Cromoglycate (DSCG) inhibits responses to platelet-activating factor (PAF-acether) in man: an alternative mode of action for DSCG in asthma? Eur J Pharmacol. 1982 Dec 17;86(1):143–144. doi: 10.1016/0014-2999(82)90415-0. [DOI] [PubMed] [Google Scholar]
  4. Batchelor J. F., Follenfant M. J., Garland L. G., Gorvin J. H., Green A. F., Hodson H. F., Hughes D. T., Tateson J. E. Doxantrazole, an antiallergic agent orally effective in man. Lancet. 1975 May 24;1(7917):1169–1170. doi: 10.1016/s0140-6736(75)93141-4. [DOI] [PubMed] [Google Scholar]
  5. Biggs D. F., Goel V. Mechanisms of action of sodium cromoglycate. Can J Physiol Pharmacol. 1985 Jun;63(6):760–765. doi: 10.1139/y85-126. [DOI] [PubMed] [Google Scholar]
  6. Boushey H. A., Holtzman M. J., Sheller J. R., Nadel J. A. Bronchial hyperreactivity. Am Rev Respir Dis. 1980 Feb;121(2):389–413. doi: 10.1164/arrd.1980.121.2.389. [DOI] [PubMed] [Google Scholar]
  7. Cairns H., Cox D., Gould K. J., Ingall A. H., Suschitzky J. L. New antiallergic pyrano [3,2-g]quinoline-2,8-dicarboxylic acids with potential for the topical treatment of asthma. J Med Chem. 1985 Dec;28(12):1832–1842. doi: 10.1021/jm00150a014. [DOI] [PubMed] [Google Scholar]
  8. Cutz E., Levison H., Cooper D. M. Ultrastructure of airways in children with asthma. Histopathology. 1978 Nov;2(6):407–421. doi: 10.1111/j.1365-2559.1978.tb01735.x. [DOI] [PubMed] [Google Scholar]
  9. DUNNILL M. S. The pathology of asthma, with special reference to changes in the bronchial mucosa. J Clin Pathol. 1960 Jan;13:27–33. doi: 10.1136/jcp.13.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. El-Azab J., Stewart P. B. Pharmacologic profile of a new antiallergic compound PRD-92-Ea. Int Arch Allergy Appl Immunol. 1977;55(1-6):350–361. doi: 10.1159/000231946. [DOI] [PubMed] [Google Scholar]
  11. Lacy E. R., Ito S. Microscopic analysis of ethanol damage to rat gastric mucosa after treatment with a prostaglandin. Gastroenterology. 1982 Sep;83(3):619–625. [PubMed] [Google Scholar]
  12. Laitinen L. A., Heino M., Laitinen A., Kava T., Haahtela T. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis. 1985 Apr;131(4):599–606. doi: 10.1164/arrd.1985.131.4.599. [DOI] [PubMed] [Google Scholar]
  13. Ligumsky M., Hansen D. G., Kauffman G. L., Jr Salicylic acid blocks indomethacin- and aspirin-induced cyclo-oxygenase inhibition in rat gastric mucosa. Gastroenterology. 1982 Nov;83(5):1043–1046. [PubMed] [Google Scholar]
  14. Morley J., Page C. P., Sanjar S. Pharmacology of the late response to allergen and its relevance to asthma prophylaxis. Int Arch Allergy Appl Immunol. 1985;77(1-2):73–78. doi: 10.1159/000233756. [DOI] [PubMed] [Google Scholar]
  15. Robert A., Nezamis J. E., Lancaster C., Hanchar A. J. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology. 1979 Sep;77(3):433–443. [PubMed] [Google Scholar]
  16. Rosam A. C., Wallace J. L., Whittle B. J. Potent ulcerogenic actions of platelet-activating factor on the stomach. Nature. 1986 Jan 2;319(6048):54–56. doi: 10.1038/319054a0. [DOI] [PubMed] [Google Scholar]
  17. Schmidt K. L., Henagan J. M., Smith G. S., Hilburn P. J., Miller T. A. Prostaglandin cytoprotection against ethanol-induced gastric injury in the rat. A histologic and cytologic study. Gastroenterology. 1985 Mar;88(3):649–659. doi: 10.1016/0016-5085(85)90132-5. [DOI] [PubMed] [Google Scholar]
  18. Walker S. R., Evans M. E., Richards A. J., Paterson J. W. The fate of ( 14 C)disodium cromoglycate in man. J Pharm Pharmacol. 1972 Jul;24(7):525–531. doi: 10.1111/j.2042-7158.1972.tb09051.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES